Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
about
Angina in Women without Obstructive Coronary Artery DiseaseIschemic heart disease in women: many questions, few factsA randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserveCreatine kinase in ischemic and inflammatory disordersSex differences in the pathophysiology, treatment, and outcomes in IHDLayer-specific analysis of dobutamine stress echocardiography for the evaluation of coronary artery diseaseCoronary autoregulation is abnormal in syndrome X: insights using myocardial contrast echocardiography.ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.Abnormal cortical pain processing in patients with cardiac syndrome X.Resolution of angina pectoris and improvement of the coronary flow reserve after ranolazine treatment in a woman with isolated impaired coronary microcirculation.Myocardial flow reserve (MFR) with positron emission tomography (PET)/computed tomography (CT): clinical impact in diagnosis and prognosis.Effect of Ranolazine in Patients with Chest Pain and Normal Coronaries- A Hospital Based Study.Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham scoreCardiovascular outcomes of a positive nuclear stress test but negative coronary angiography in a multiethnic male predominant cohort.Effects of sex on coronary microvascular dysfunction and cardiac outcomes.Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease.The research on endothelial function in women and men at risk for cardiovascular disease (REWARD) study: methodology.Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group.Evolving strategies for the treatment of microvascular angina in women.Gender comparisons in non-acute cardiac symptom recognition and subsequent help-seeking decisions: a mixed methods study protocolAn intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).Cardiac syndrome X: Clinical characteristics revisited.Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and managementInvasive and noninvasive assessment of exercise-induced ischemic diastolic response using pressure transducersEffect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary studyAlexithymia and anxiety sensitivity in patients with non-cardiac chest pain.Global Coronary Artery Plaque Area is Associated with Myocardial Hypoperfusion in Women with Non-ST Elevation Myocardial Infarction.Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) studyMyocardial ischemia in women: lessons from the NHLBI WISE study.Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms.Prognostic significance of coronary sinus filling time in patients with angina and normal coronaries at one year follow up.Stress testing and non-invasive coronary angiography in patients with suspected coronary artery disease: time for a new paradigm.Long-term prognosis of patients with cardiac syndrome X: a review.Finding the Gatekeeper to the Cardiac Catheterization Laboratory: Coronary CT Angiography or Stress Testing?Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD.Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation StudySymptoms across the continuum of acute coronary syndromes: differences between women and men.Takotsubo cardiomyopathy--a clinical reviewAdrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
P2860
Q24613443-1A86DC11-7D6D-470C-BE8E-FEDBF34B5C87Q24618941-D59F1D27-086E-468E-9209-5AC0EB2817E4Q26776330-03B3D774-28A0-4F65-A32D-174789047DB2Q28069271-9B66E03C-74A1-4566-8EC7-40B5981DCC16Q28084204-812F3199-9BDF-4BDA-882F-C8C46BD24295Q30375854-D6F60B28-BD67-4DD1-B7F3-639872C99D56Q30442350-8261DBEC-0CEA-4F62-BE45-721FF5E57E0FQ30475186-21A99F7F-399C-413E-872B-D2DF16561A1CQ33213220-BA5CDA54-5660-4154-A3B5-52F8723B5671Q33559253-191CC2AA-BF10-4B3E-BB63-F7D24B5163EDQ33651049-97D16E81-7F2F-46C0-9E25-30A9E0F3FA3DQ33741730-51B9A54D-9F22-44A4-87BE-6FBB0CD00E6FQ33788911-E9CD2385-FBF5-45AE-BCEC-E72509732A75Q33809242-61EFE83C-D2F5-46FF-9232-D95F28D42567Q33825527-2FFE283C-0FD4-4B14-A083-7A08F58FBD1DQ33841979-B1A6232E-E83D-4969-9F1C-62E2B82B6706Q33989516-E5ACBF28-58AA-4FF3-A129-D1F0D2CBED7DQ34002717-33A9E9BF-C6F4-4ECA-9E52-30A7AB56C9C5Q34317991-1EDDFBD2-3EDC-476C-81BB-BB0A0D55B60FQ34439065-53196500-17E1-4E8E-84E3-A426E1781D3DQ34481332-450FBB9B-5309-4140-A6C7-6EF66412BC14Q34672555-761F9C34-B098-43C2-A019-F5E6B63CFF18Q35093085-69E3CA44-1CC3-4DCB-B716-136E9F63C028Q35139982-ECE8711A-8623-4307-A5CA-CBFD5F85CA35Q35149912-AC280C35-8143-4E90-AD2E-6DE962C2CED7Q35154165-F9D4E258-BB25-4069-9C47-D04D13FAF15BQ35635306-2D3CB95A-BD24-40A0-AC79-918B6EB6539FQ35754796-136A8757-B607-4603-852F-1C174D074330Q35816400-860B659E-C459-41B5-9DB2-29D8A83BF0DAQ35820618-A735A6E6-D25E-4C0E-A68B-D2A06238F21BQ35830825-8DE39D72-FD5E-4E9A-931B-F175AE2B4614Q36004976-62AEFE42-8141-41EB-8081-EE0842A38763Q36198796-4BF10A7D-8C0D-4532-B53A-1CBD3300F8EDQ36200819-D5775023-D5D1-46A4-AADE-BD7F549FE554Q36202061-C2A9D41D-43F6-4FE2-A164-1C3D0BFC3FC6Q36247712-6481971D-DEB9-42A6-BC58-20D7CFDABA4AQ36351005-87C6063D-2C7F-496F-A18E-7D28B544E42AQ36478363-F0EDB081-7A12-47E7-886A-98688A3E96D0Q36516492-339062AD-C74B-47C2-A6C5-F81C73EB264AQ36579138-AA55DCAA-6E85-45BA-BB14-FECDA7041BF0
P2860
Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Prognosis in women with myocar ...... ia Syndrome Evaluation (WISE).
@en
Prognosis in women with myocar ...... ia Syndrome Evaluation (WISE).
@nl
type
label
Prognosis in women with myocar ...... ia Syndrome Evaluation (WISE).
@en
Prognosis in women with myocar ...... ia Syndrome Evaluation (WISE).
@nl
prefLabel
Prognosis in women with myocar ...... ia Syndrome Evaluation (WISE).
@en
Prognosis in women with myocar ...... ia Syndrome Evaluation (WISE).
@nl
P2093
P1433
P1476
Prognosis in women with myocar ...... ia Syndrome Evaluation (WISE).
@en
P2093
B Delia Johnson
Barry Sharaf
C Noel Bairey Merz
Carl J Pepine
Gerald M Pohost
Hee-Won Kim
Jan den Hollander
John R Forder
Katherine N Scott
Leslee J Shaw
P304
P356
10.1161/01.CIR.0000130642.79868.B2
P407
P577
2004-06-14T00:00:00Z